The refractory headache patient-II. High medication consumption (analgesic rebound) headache

Denise M. Michultka, Edward B. Blanchard, Kenneth A. Appelbaum, James Jaccard, Mark P. Dentinger

Research output: Contribution to journalArticle

Abstract

'Analgesic rebound headache' is identified by habituation of an individual to pain reducing medication, the exacerbation of headache pain a few hours after medication consumption and a marked increase in headache frequency and intensity for several weeks after medication is discontinued. We describe three studies undertaken to clarify the existence and characteristics of this proposed headache syndrome. In Study 1 we compared a group of headache sufferers who consume large amounts of analgesic medications to headache sufferers who did not consume excessive analgesics. It was found that the two groups did not differ on age, duration of headache problem or gender. However, the groups did differ on subjective headache pain (with the high medicators experiencing more headache pain than low medicators) and diagnosis (with high medicators being more likely to have a muscle contraction component to their headaches). In an analysis of drug use within the high medication group, it was found that 91% were taking some kind of analgesic and that a majority (84%) were taking more than one type of medication. In Study 2 we found that the group of high medicators were not as successful in reducing headache activity as a result of a self-regulatory behavioral treatment as the matched controls. Furthermore, there was a direct relationship between reduction and treatment success in the high medication consuming population. Lastly, in Study 3 we examined the current psychological functioning of the two groups; no differences were found between the two groups indicating the lack of 'addictive' personality characteristics as an explanation for the high medicating population. These findings all support the existence of a sub-population of headache sufferers who consume excessive amounts of analgesic medication and who are relatively refractory to behavioral treatment.

Original languageEnglish (US)
Pages (from-to)411-420
Number of pages10
JournalBehaviour Research and Therapy
Volume27
Issue number4
DOIs
StatePublished - 1989

Fingerprint

Secondary Headache Disorders
Headache
Analgesics
Pain
Population
Headache Disorders
Muscle Contraction

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

The refractory headache patient-II. High medication consumption (analgesic rebound) headache. / Michultka, Denise M.; Blanchard, Edward B.; Appelbaum, Kenneth A.; Jaccard, James; Dentinger, Mark P.

In: Behaviour Research and Therapy, Vol. 27, No. 4, 1989, p. 411-420.

Research output: Contribution to journalArticle

Michultka, Denise M. ; Blanchard, Edward B. ; Appelbaum, Kenneth A. ; Jaccard, James ; Dentinger, Mark P. / The refractory headache patient-II. High medication consumption (analgesic rebound) headache. In: Behaviour Research and Therapy. 1989 ; Vol. 27, No. 4. pp. 411-420.
@article{b2f7e004ec394c458796ddb859fcaf4c,
title = "The refractory headache patient-II. High medication consumption (analgesic rebound) headache",
abstract = "'Analgesic rebound headache' is identified by habituation of an individual to pain reducing medication, the exacerbation of headache pain a few hours after medication consumption and a marked increase in headache frequency and intensity for several weeks after medication is discontinued. We describe three studies undertaken to clarify the existence and characteristics of this proposed headache syndrome. In Study 1 we compared a group of headache sufferers who consume large amounts of analgesic medications to headache sufferers who did not consume excessive analgesics. It was found that the two groups did not differ on age, duration of headache problem or gender. However, the groups did differ on subjective headache pain (with the high medicators experiencing more headache pain than low medicators) and diagnosis (with high medicators being more likely to have a muscle contraction component to their headaches). In an analysis of drug use within the high medication group, it was found that 91{\%} were taking some kind of analgesic and that a majority (84{\%}) were taking more than one type of medication. In Study 2 we found that the group of high medicators were not as successful in reducing headache activity as a result of a self-regulatory behavioral treatment as the matched controls. Furthermore, there was a direct relationship between reduction and treatment success in the high medication consuming population. Lastly, in Study 3 we examined the current psychological functioning of the two groups; no differences were found between the two groups indicating the lack of 'addictive' personality characteristics as an explanation for the high medicating population. These findings all support the existence of a sub-population of headache sufferers who consume excessive amounts of analgesic medication and who are relatively refractory to behavioral treatment.",
author = "Michultka, {Denise M.} and Blanchard, {Edward B.} and Appelbaum, {Kenneth A.} and James Jaccard and Dentinger, {Mark P.}",
year = "1989",
doi = "10.1016/0005-7967(89)90012-0",
language = "English (US)",
volume = "27",
pages = "411--420",
journal = "Behaviour Research and Therapy",
issn = "0005-7967",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - The refractory headache patient-II. High medication consumption (analgesic rebound) headache

AU - Michultka, Denise M.

AU - Blanchard, Edward B.

AU - Appelbaum, Kenneth A.

AU - Jaccard, James

AU - Dentinger, Mark P.

PY - 1989

Y1 - 1989

N2 - 'Analgesic rebound headache' is identified by habituation of an individual to pain reducing medication, the exacerbation of headache pain a few hours after medication consumption and a marked increase in headache frequency and intensity for several weeks after medication is discontinued. We describe three studies undertaken to clarify the existence and characteristics of this proposed headache syndrome. In Study 1 we compared a group of headache sufferers who consume large amounts of analgesic medications to headache sufferers who did not consume excessive analgesics. It was found that the two groups did not differ on age, duration of headache problem or gender. However, the groups did differ on subjective headache pain (with the high medicators experiencing more headache pain than low medicators) and diagnosis (with high medicators being more likely to have a muscle contraction component to their headaches). In an analysis of drug use within the high medication group, it was found that 91% were taking some kind of analgesic and that a majority (84%) were taking more than one type of medication. In Study 2 we found that the group of high medicators were not as successful in reducing headache activity as a result of a self-regulatory behavioral treatment as the matched controls. Furthermore, there was a direct relationship between reduction and treatment success in the high medication consuming population. Lastly, in Study 3 we examined the current psychological functioning of the two groups; no differences were found between the two groups indicating the lack of 'addictive' personality characteristics as an explanation for the high medicating population. These findings all support the existence of a sub-population of headache sufferers who consume excessive amounts of analgesic medication and who are relatively refractory to behavioral treatment.

AB - 'Analgesic rebound headache' is identified by habituation of an individual to pain reducing medication, the exacerbation of headache pain a few hours after medication consumption and a marked increase in headache frequency and intensity for several weeks after medication is discontinued. We describe three studies undertaken to clarify the existence and characteristics of this proposed headache syndrome. In Study 1 we compared a group of headache sufferers who consume large amounts of analgesic medications to headache sufferers who did not consume excessive analgesics. It was found that the two groups did not differ on age, duration of headache problem or gender. However, the groups did differ on subjective headache pain (with the high medicators experiencing more headache pain than low medicators) and diagnosis (with high medicators being more likely to have a muscle contraction component to their headaches). In an analysis of drug use within the high medication group, it was found that 91% were taking some kind of analgesic and that a majority (84%) were taking more than one type of medication. In Study 2 we found that the group of high medicators were not as successful in reducing headache activity as a result of a self-regulatory behavioral treatment as the matched controls. Furthermore, there was a direct relationship between reduction and treatment success in the high medication consuming population. Lastly, in Study 3 we examined the current psychological functioning of the two groups; no differences were found between the two groups indicating the lack of 'addictive' personality characteristics as an explanation for the high medicating population. These findings all support the existence of a sub-population of headache sufferers who consume excessive amounts of analgesic medication and who are relatively refractory to behavioral treatment.

UR - http://www.scopus.com/inward/record.url?scp=0024335832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024335832&partnerID=8YFLogxK

U2 - 10.1016/0005-7967(89)90012-0

DO - 10.1016/0005-7967(89)90012-0

M3 - Article

VL - 27

SP - 411

EP - 420

JO - Behaviour Research and Therapy

JF - Behaviour Research and Therapy

SN - 0005-7967

IS - 4

ER -